Startup Renovion, its marketing slogan “Restoring Lung Health One Breath at a Time,” has gotten two doses of fresh air for its treatment efforts.
Read More
Researchers have developed an inhalable powder – called SHIELD – that could protect lungs and airways from viral invasion by reinforcing the body’s own mucosal layer.
Read More
Polarean Imaging, a Durham-based medical imaging technology company, has received regulatory clearance for a drug and device combination product that helps doctors visualize lung function in patients with chronic lung disease.
Read More
Aer Therapeutics,a startup focusing on lung disease and what it calls “a novel inhaled approach” for treatment, has closed on $15.8 million in funding from 23 investors. But the company wants a lot more.
Read More
Raleigh digital health startup VitalFlo has formed a partnership with the Allergy & Asthma Network which opens an opportunity to work with the network’s more than 2 million partners and patients.
Read More
UNC School of Medicine lab of Mehmet Kesimer has further illuminated the molecular intricacies of mucus and its role in pulmonary diseases, laying more groundwork for better therapies for chronic obstructive pulmonary disease and other airway conditions. The findings are published in the Proceedings of the National Academy of Sciences.
Read More
An investigational antibody in clinical trials for lung cancer appears to disrupt a mechanism that tumor cells exploit to avoid being destroyed by the body’s innate immune system, researchers at Duke Health report.
Read More
Verona Pharma has clinched a $219 million deal to market its “first-in-class” drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD), in China.
Read More
Renovian said the funds would support the development and clinical programs associated with their lead therapeutic candidate ARINA-1.
Read More
